CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atkinson, C.
Right arrow Articles by Lampe, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkinson, C.
Right arrow Articles by Lampe, J. W.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 253-260, March 2002
© 2002 American Association for Cancer Research

Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake1

Charlotte Atkinson, Heather E. Skor, E. Dawn Fitzgibbons, Delia Scholes, Chu Chen, Kristiina Wähälä, Stephen M. Schwartz and Johanna W. Lampe2

Cancer Prevention Research Program [C. A., H. E. S., J. W. L.] and Program in Epidemiology [E. D. F., C. C., S. M. S.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington 98101 [D. S.]; University of Helsinki, Helsinki, Finland [K. W.]; and Department of Epidemiology, University of Washington, Seattle, Washington 98195 [D. S., S. M. S.]

Dietary isoflavones are biologically active in humans, but few observational data exist on the relationship between isoflavone intake and excretion in Western populations. We examined associations between self-reported soy intakes and overnight urinary isoflavone excretion in a population-based sample of western Washington State women, and we investigated the usefulness of one versus two overnight urine samples, collected 48 h apart, as a biomarker of intake. Isoflavones (genistein, daidzein, O-desmethylangolensin, and equol) were measured in two overnight urine collections from 363 women recruited from a health maintenance organization. Soy food intakes were assessed using two 1-day diet records completed on each day prior to the urine collections and a food frequency questionnaire (FFQ) that had been completed by 312 of the women with regard to their dietary habits 3.5 years (range, 2–5 years) before the urine collections. Twenty-one percent of the women consumed soy on either day of the diet recall, and 13% and 34% of the women consumed soy at least once a week or at least once a month, respectively, according to the FFQ. Women who consumed soy at either of the two diet recalls or at the FFQ (at least once a week or at least once a month) had a significantly higher urinary excretion of isoflavones than women who did not consume soy (P < 0.01). Among women who consumed soy at either of the two diet recalls or at the FFQ (soy consumed at least once a month), isoflavone intake and excretion correlated significantly (P < 0.01). Excretion of the individual isoflavones correlated significantly between the two urine samples collected 48 h apart (genistein, r = 0.41 and P < 0.001; daidzein, r = 0.30 and P < 0.001; O-desmethylangolensin, r = 0.46 and P < 0.001; equol, r = 0.60 and P < 0.001). Differences between soy consumers and nonconsumers and associations between intakes and excretion remained significant whether one or both urine collections were considered. Measuring isoflavone excretion in one overnight urine collection serves as a biomarker of recent or past isoflavone intake, even in populations whose intake of soy foods is relatively low.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
K. Jaceldo-Siegl, G. E Fraser, J. Chan, A. Franke, and J. Sabate
Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1422 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. R Walsh, S. J Haak, T. Bohn, Q. Tian, S. J Schwartz, and M. L Failla
Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1050 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Atkinson, J. W Lampe, D. Scholes, C. Chen, K. Wahala, and S. M Schwartz
Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States.
Am. J. Clinical Nutrition, September 1, 2006; 84(3): 587 - 593.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi
Isoflavones in breastfed infants after mothers consume soy.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe
Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health
Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez
Polyphenols: food sources and bioavailability
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. B. Grace, J. I. Taylor, Y.-L. Low, R. N. Luben, A. A. Mulligan, N. P. Botting, M. Dowsett, A. A. Welch, K.-T. Khaw, N. J. Wareham, et al.
Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 698 - 708.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Atkinson, S. Berman, O. Humbert, and J. W. Lampe
In Vitro Incubation of Human Feces with Daidzein and Antibiotics Suggests Interindividual Differences in the Bacteria Responsible for Equol Production
J. Nutr., March 1, 2004; 134(3): 596 - 599.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.